Karl Härfstrand

Karl Anders Olof Härfstrand is the founder of Härfstrand Consulting AG, serving as Chairman since 2010.
Current job includes Director at Karolinska Development AB since 2025.
Former jobs include President & Chief Executive Officer-Europe at ADAMA Agricultural Solutions Ltd. from 2013 to 2014, Chief Executive Officer & Director at Horizon Therapeutics Switzerland GmbH from 2007 to 2010, Chief Executive Officer at to-BBB Holding BV from 2014 to 2015, Chief Executive Officer at to-BBB technologies BV from 2014 to 2015, President & Chief Executive Officer at ADAMA Agriculture BV from 2013 to 2014, President & Chief Executive Officer at Humabs BioMed SA from 2011 to 2012, Independent Non-Executive Chairman at Vivesto AB from 2020 to 2022, Non-Executive Chairman at Neurocrine Group Ltd. from 2021 to 2022, Chairman at Brain+ A from 2022 to 2024, Director at Acino International AG from 2008 to 2013, Director at Ascenditur AB, Director at OphthalmoPharma AG, Director at HeiQ Materials AG, Director & Executive Vice President at Pfizer Japan, Inc. in 2005, Independent Director at Karolinska Development AB from 2017 to 2019, Independent Director at Prothena Corp.
Plc from 2015 to 2024, Vice President-Country Operations at Pharmacia & Upjohn, Inc. from 1988 to 2003, Vice President-Country Operations at Pharmacia AB from 1988 to 2003, Senior Executive Vice President at EMD Serono, Inc. from 2005 to 2007, Principal at Pharmacia, Inc. in 2003, and Senior Executive Vice President at Serono International SA in 2010.
Education includes a doctorate from Karolinska Institutet, conferred in 1987.